Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

Aim: Sex-specific analyses of direct head-to-head comparisons between newer P2Y(12) inhibitors are limited. This study was conducted to assess the efficacy and safety of ticagrelor versus prasugrel in women and men with acute coronary syndromes (ACS) planned for an invasive strategy. Methods: This p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gewalt, Senta, Lahu, Shqipdona, Ndrepepa, Gjin, Pellegrini, Costanza, Bernlochner, Isabell, Neumann, Franz-Josef, Menichelli, Maurizio, Morath, Tanja, Witzenbichler, Bernhard, Wöhrle, Jochen, Hoppe, Katharina, Richardt, Gert, Laugwitz, Karl-Ludwig, Schunkert, Heribert, Kastrati, Adnan, Schüpke, Stefanie, Mayer, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135658/
https://www.ncbi.nlm.nih.gov/pubmed/33867409
http://dx.doi.org/10.5551/jat.62776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135658/
https://www.ncbi.nlm.nih.gov/pubmed/33867409
http://dx.doi.org/10.5551/jat.62776

Ejemplares similares